- All sections
- A - Human necessities
- A61K - Preparations for medical, dental or toiletry purposes
- A61K 9/46 - Pills, lozenges or tablets effervescent
Patent holdings for IPC class A61K 9/46
Total number of patents in this class: 360
10-year publication summary
|
34
|
40
|
41
|
33
|
41
|
20
|
33
|
22
|
17
|
5
|
| 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
Principal owners for this class
| Owner |
All patents
|
This class
|
|---|---|---|
| Dr. Falk Pharma GmbH | 162 |
10 |
| Amerilab Technologies, Inc. | 25 |
9 |
| The Procter & Gamble Company | 22020 |
8 |
| SpecGx LLC | 183 |
8 |
| Sanovel Ilac Sanayi ve Ticaret A.S. | 277 |
7 |
| Galderma Research & Development | 406 |
6 |
| Steerlife India Private Limited | 28 |
6 |
| Symrise AG | 1716 |
6 |
| Cephalon, Inc. | 116 |
5 |
| Georgia Tech Research Corporation | 2709 |
4 |
| ABIC Biological Laboratories Ltd. | 8 |
4 |
| Tower Laboratories, Ltd. | 20 |
4 |
| Nicoventures Trading Limited | 3783 |
4 |
| Amneal Complex Products Research LLC | 65 |
4 |
| Hermes Pharma GmbH | 17 |
4 |
| The Regents of the University of California | 19803 |
3 |
| AstraZeneca AB | 2928 |
3 |
| Bayer HealthCare LLC | 1360 |
3 |
| The General Hospital Corporation | 4701 |
3 |
| Alpex Pharma S.A. | 24 |
3 |
| Other owners | 256 |